Form 8-K - Current report:
SEC Accession No. 0001104659-25-031194
Filing Date
2025-04-02
Accepted
2025-04-02 16:23:55
Documents
14
Period of Report
2025-04-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2511071d1_8k.htm   iXBRL 8-K 38374
2 EXHIBIT 99.1 tm2511071d1_ex99-1.htm EX-99.1 25740
  Complete submission text file 0001104659-25-031194.txt   251841

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA enfn-20250402.xsd EX-101.SCH 3014
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE enfn-20250402_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enfn-20250402_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2511071d1_8k_htm.xml XML 3801
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 25805014
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)